论文部分内容阅读
作者分析149例严重再生障碍性贫血再障患者,其中20例(13.4％)伴有肝炎。每例在再障诊断前8个月内均被诊断为临床肝炎,肝炎发生前均未输过血制品或用过血液沾染器械作接种。选16例血清学资料完整者作为研究对象,称肝炎伴再障组,对照组为10例严重再障患者,再障前无肝炎或接触血制品史,多项肝功能检查均正常。所有26例患者均因再障输注了包括红细胞、血小板和粒细胞在内的大量血制品。患者在入院时采血清标本,检测甲型和乙型肝炎
The authors analyzed 149 patients with aplastic anemia of aplastic anemia, of which 20 (13.4%) with hepatitis. Each case was diagnosed as clinical hepatitis within 8 months before the diagnosis of aplastic anemia, and no blood products or blood-stained instruments were used for inoculation before the occurrence of hepatitis. Sixteen patients with complete serological data were selected as study subjects and were referred to as hepatitis with aplastic anemia. The control group included 10 patients with severe aplastic anemia. There was no history of hepatitis or contact with blood products prior to aplastic anemia. A number of liver function tests were normal. All 26 patients were infused with a large number of blood products including red blood cells, platelets and granulocytes due to aplastic anemia. Patients admitted to hospital when the serum samples, test for hepatitis A and B.